Skip to main content
. 2014 Feb 5;18(1):R26. doi: 10.1186/cc13716

Table 3.

Treatment indication, modality, and anticoagulation of renal replacement therapy (RRT) in the low-RRT and high-RRT intensive care units (ICUs)

  Low-RRT ICUs (n = 33) High-RRT ICUs (n = 98) P value
Indication of RRT
 
 
 
Oliguria
29 (87.9)
83 (84.7)
0.7
High creatinine
25 (75.8)
54 (55.1)
0.04
Acidosis
24 (72.7)
72 (73.5)
0.9
Hyperkalemia
9 (27.3)
20 (20.4)
0.4
Fluid overload
12 (36.4)
43 (43.9)
0.4
Intoxication
2 (6.1)
3 (3.0)
0.4
Modality of RRT
 
 
 
  Only CRRT during ICU
20 (60.6)
52 (53.1)
0.5
  Only IRRT during ICU
2 (6.1)
11 (11.2)
0.4
  Both CRRT + IRRT during ICU
11 (33.3)
35 (35.7)
0.8
Time to initiation of RRT from ICU admission (hours)
17.8 [5.2–33.7]
13.5 [5.2–33.2]
0.9
Received anticoagulation
32 (97)
83 (84.7)
0.06
  Citrate
23 (69.7)
40 (40.8)
0.004
  LMWH
18 (54.5)
65 (66.3)
0.2
  Other
0
7 (7.1)
0.1
  None
4 (12.1)
27 (27.6)
0.07
Complications related to RRT
  Complication in insertion of catheter
8 (24.2)
10 (10.2)
0.04
  Electrolyte disturbances
7 (21.2)
19 (19.4)
0.8
  Hypotension during RRT
1 (3.0)
2 (2.0)
0.7
  Bleeding
2 (6.1)
1 (1.0)
0.09
  Catheter-related infection 0 1 (1.0) 0.6

Values are expressed as count (%) and median [interquartile range]. CRRT, continuous renal replacement therapy; IRRT, intermittent renal replacement therapy; LMWH, low-molecular-weight heparin.